Patients with hematologic malignancies frequently become thrombocytopenic as a result of their underlying malignancy or treatments, including cytotoxic chemotherapy and hematopoietic stem cell transplantation and are at increased risk of…
Jeanne E. Hendrickson, MD, Editor Christopher A. Tormey, MD, Editor Transfusion is essential for the care of a great number of individuals with Hematologic and Oncologic disorders; pediatric and adult…
Anemia in patients with malignancy is common as a consequence of their disease and treatment. Substantial progress has been made in the management of anemia with red blood cell transfusion…
